38 reports

  • Liver Cancer Overview
  • III. LIVER CANCER TREATMENT DRUGS

China’s demand for Liver Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Liver Cancer
  • China
  • Demand
  • Novartis AG
  • Sanofi-Synthelabo Inc.
  • Liver Cancer Overview
  • Liver Cancer Treatment Drugs Sales Volume by

This study focuses on China’s Liver Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Liver Cancer
  • China
  • Demand
  • Trade
  • Hainan Haiyao Company Limited
  • Liver Cancer Treatment Drugs Industry Structure
  • Liver Cancer Treatment Drugs Sales Volume

This study focuses on China’s Liver Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Liver Cancer
  • China
  • Biostar Pharmaceuticals, Inc.
  • Novartis AG
  • Sanofi-Synthelabo Inc.

Liver Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class, By Country And Segment Forecasts, 2016 - 2022 Chapter ## Research Methodology ##. ##.

  • Cancer
  • Liver Cancer
  • United Kingdom
  • United States
  • Forecast

Liver cancer -Epidemiology Forecast to 2027 ##.

  • Liver Cancer
  • France
  • Germany
  • Italy
  • Spain

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Liver Cancer
  • France
  • United States
  • Market Shares
  • Market Size

Drug A: Company ## ##. ##. ##.

  • Cancer
  • Liver Cancer
  • United States
  • Market Shares
  • Incidence of Liver cancer, total (000s)
  • FEATURES OF LIVER CANCER PATIENTS

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Liver Cancer in 18 Major Markets Liver Cancer, also known as hepatic cancer or primary liver cancer, is a cancer which starts in the cells of the liver. The most common form is hepatocellular carcinoma (HCC) which originates from hepatocytes, the most abundant cell type...

  • Cancer
  • Hepatitis
  • Liver Cancer
  • Pathology

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Liver Cancer
  • France
  • Germany
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Japan
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • United States
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Italy
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Germany
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • France
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • United Kingdom
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Spain
  • Market Shares
  • Market Size
  • 4.4.1 United States - Liver Cancer Biopsy Test Market & Forecast
  • 4.4 United States - Liver Cancer Biopsy Test Market & Volume

United States – Biopsy Testing Market – Overview United States Biopsy Test Market was more than US$ 15 Billion in 2014 and future seems to be much brighter. In the United States Biopsy Test Market, Breast Cancer is the most popular segment in 2014. Thyroid cancer stands at the last spot, but it is the most rapidly increasing...

  • Biopsy
  • Liver Cancer
  • Prostate Cancer
  • United States
  • Forecast
  • 6.5 United States - Liquid Biopsy Liver Cancer Screening Potential
  • 7.5 United States - Liquid Biopsy Liver Cancer Treatment Monitoring

United States – Liquid Biopsy Testing Market - Overview Liquid Biopsy Tests are emerging as a viable alternative to traditional methods for cancer screening. A liquid biopsy is a new type of blood test that has the potential to transform cancer treatment. Using this methodology, physicians avoid the traditional surgical and needle...

  • Diagnostics
  • Liver Cancer
  • United States
  • Forecast
  • Biocept, Inc.
  • EARLYCDT - LIVER CANCER KIT - PRODUCT DESCRIPTION
  • EARLYCDT - LIVER CANCER KIT - PRODUCT STATUS

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Liver Cancer Diagnostic Tests currently in pipeline stage. The report...

  • Biomarker
  • Clinical Trial
  • Hepatitis
  • Liver Cancer
  • Pfizer Inc.
  • BREAKDOWN OF LIVER CANCER INTO DIFFERENT CATEGORIES
  • SHOWS THE BREAKDOWN OF LIVER CANCER INTO DIFFERENT CATEGORIES.

Opportunity Analyzer: Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2024 Summary Liver cancer is the second leading cause of cancer related death in the world in men and the sixth leading cause of cancer death in women. Hepatocellular carcinoma (HCC) is the most dominant form of liver cancer,...

  • Liver Cancer
  • Celsion Corporation
  • Eli Lilly & Co.
  • GlobalData's company
  • ThermoDox® group
  • Symptoms of Liver Cancer
  • Liver Cancer, PRKCD Targeting Products

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation Summary Liver plays various vital roles within the body, including the removal of toxins from the blood, the production of bile to help digest fat and substances to help blood clot, in addition to making, storing and releasing...

  • Cancer
  • Hepatitis
  • Liver Cancer
  • Pathology
  • World

The report focuses on drugs and therapies being evaluated for Metastatic Liver Cancer treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Cancer
  • Clinical Trial
  • Drug Discovery And Development
  • Liver Cancer
  • Pathology

Liver cancer Pipeline Highlights – 2017 ##.

  • Cancer
  • Liver Cancer
  • United States
  • Product Initiative
  • Liver Cancer Overview
  • Liver Cancer - Dormant Projects

Liver Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of the Liver Cancer (Oncology) pipeline landscape. Liver cancer starts in the liver. The risk factors for liver cancer...

  • Liver Cancer
  • Therapy
  • United States
  • Company
  • Product Initiative

Metastatic Liver Cancer - Pipeline Insight, 2018 ##.

  • Liver Cancer
  • Therapy
  • Metastatic Liver Cancer - Dormant Projects
  • Metastatic Liver Cancer - Therapeutics Assessment

Metastatic Liver Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Metastatic Liver Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Liver Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Liver...

  • Liver Cancer
  • Therapy
  • United States
  • Company Operations
  • Product Initiative
  • Liver Cancer Overview
  • Liver Cancer - Discontinued Products

Liver Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Liver Cancer, complete with analysis by stage of...

  • Cell Therapy
  • Liver Cancer
  • United States
  • Company
  • Product Initiative
  • LIVER CANCER - PIPELINE PRODUCTS BY TERRITORY
  • LIVER CANCER - PIPELINE PRODUCTS BY TERRITORY

Liver Cancer - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Liver Cancer - Pipeline Review, 2015" provides an overview of Liver Cancer diagnostic tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the...

  • Clinical Trial
  • Drug Discovery And Development
  • Liver Cancer
  • Company
  • GlobalData's company

Metastatic Liver Cancer - Pipeline Review, H## 2015 Table of Contents Table of Contents ## List of Tables ## List of Figures ## Introduction ## Global Markets Direct Report Coverage ## Metastatic Liver Cancer Overview ## Therapeutics Development ## Pipeline Products for Metastatic

  • Liver Cancer
  • Therapy
  • World
  • SEP 04, 2018: TOP LINE RESULTS OF THE NAMODENOSON PHASE II ADVANCED LIVER CANCER TRIAL EXPECTED BY END OF YEAR
  • JUL 02, 2018: DRUGS WITH MECHANISM OF ACTION UTILIZED BY NAMODENOSON ARE RECOMMENDED BY LEADING U.S. RESEARCHERS TO BE DEVELOPED TO COMBAT LIVER CANCER

Adenosine Receptor A3 (ADORA3) - Pipeline Review, H2 2018 Summary Adenosine Receptor A3 (ADORA3) pipeline Target constitutes close to 17 molecules. Out of which approximately 16 molecules are developed by companies and remaining by the universities/institutes. The latest report Adenosine Receptor...

  • Autoimmune Disease
  • Cardiovascular Drug
  • Liver Cancer
  • Therapy
  • Can-Fite BioPharma Ltd.